Esketamine's Role in Elderly Lung Surgery Recovery: Clinical Insights

Esketamine's Impact on Postoperative Recovery

A recent randomized controlled trial has demonstrated that an esketamine-based multimodal low-opioid anesthesia strategy can significantly enhance the quality of recovery in elderly patients undergoing radical lung cancer surgery. This study, published on May 28, 2026, highlights the potential of esketamine in improving physiological comfort, emotional state, and pain management during the postoperative period.

Mechanism and Context

The trial involved 144 patients aged 60 years or older, all undergoing elective thoracoscopic radical lung cancer resection. Participants were divided into two groups: one receiving a multimodal low-opioid strategy incorporating esketamine (K Group) and the other receiving a conventional opioid-based strategy (C Group). The K Group received esketamine during anesthesia induction and maintenance, leading to higher Quality of Recovery Scale-15 (QoR-15) scores on postoperative day 3 compared to the C Group. This improvement was primarily observed in physiological comfort, emotional state, and pain management.

Policy and Research Implications

The findings suggest a potential shift in anesthesia practices, particularly for elderly populations who are more vulnerable to the effects of surgery and anesthesia. By reducing the need for opioids and improving recovery outcomes, esketamine-based strategies could influence pain management protocols and perioperative care guidelines. This aligns with ongoing efforts to minimize opioid use in clinical settings, addressing both patient safety and public health concerns.

Risks and Unknowns

While the trial results are promising, further research is necessary to fully understand the long-term effects and safety profile of esketamine in this context. The study reported a lower incidence of postoperative nausea and vomiting in the esketamine group, but other adverse effects such as dizziness, headache, and drowsiness were comparable between the two groups. Continued monitoring and larger-scale studies are essential to confirm these findings and assess potential risks.

Looking Forward

This study opens new avenues for research into the use of esketamine in surgical settings, particularly for elderly patients. Future investigations could explore its application in other types of surgeries and patient populations, potentially leading to broader changes in anesthesia protocols. As the medical community seeks to enhance patient recovery and reduce opioid dependency, esketamine may play a crucial role in shaping the future of perioperative care.